{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:45Z","timestamp":1792801485081,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dyslipidemia, a major contributor to cardiovascular diseases, is rapidly increasing in Asian countries including Bangladesh. In addition to the cardiovascular system, abnormal lipid levels are also known to cause complications in renal and hepatic systems. The data regarding dyslipidemia and its relationship with liver enzymes are scarce for the Bangladeshi population. Therefore, this study was conducted to estimate the prevalence of dyslipidemia and determine the relationship between lipid profile and liver enzymes in Bangladeshi adults. A total of 405 participants (318 males and 87 females) were enrolled in the study. Serum levels of TG, TC, LDL, HDL and liver enzymes including ALT, AST, GGT and ALP were analyzed using standard methods. Dyslipidemia and liver function tests abnormalities were defined according to the international standard guidelines. The association between elevated lipid profile markers and liver enzyme abnormalities was assessed by logistic regression analysis. Overall, the prevalence of elevated TG, TC, LDL and low HDL were 30.9%, 23.7%, 26.2% and 78.8%, respectively. On the other hand, the prevalence of elevated liver enzymes ALT, AST, GGT and ALP were 18.8%, 21.6%, 12.9% and 21.9%, respectively. Dyslipidemia and liver enzyme abnormalities were higher in diabetic and hypertensive participants than in the healthy participants. About 61% of participants with dyslipidemia had at least one or more elevated liver enzymes. In regression analysis, an independent association was observed between serum GGT and all lipid components. In conclusion, a high prevalence of dyslipidemia and liver enzyme abnormalities were observed among the study participants. Of the four liver enzymes, the serum levels of GGT showed an independent association with all lipid components. Moreover, this study indicates that subjects with dyslipidemia often have a higher chance of having liver diseases than subjects with no dyslipidemia. However, large-scale prospective studies are needed to understand the underlying mechanisms of lipid-induced hepatic dysfunction in the Bangladeshi population.<\/jats:p>","DOI":"10.1038\/s41598-022-05766-y","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T11:06:03Z","timestamp":1643799963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults"],"prefix":"10.1038","volume":"12","author":[{"given":"Rahanuma Raihanu","family":"Kathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Hasan","family":"Sumon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noyan Hossain","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmudul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakib","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira Rashid","family":"Tuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-0887","authenticated-orcid":false,"given":"Nurshad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"5766_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.NPR.0000550246.96902.de","volume":"44","author":"NA Ciffone","year":"2019","unstructured":"Ciffone, N. A. & Copple, T. Managing dyslipidemia for CVD prevention: A review of recent clinical practice guidelines. Nurse Pract. 44, 8\u201316 (2019).","journal-title":"Nurse Pract."},{"key":"5766_CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D. & Catapano, A. L. Global epidemiology of dyslipidaemias. Nat. Rev. Cardiol 18, 689\u2013700 (2021).","journal-title":"Nat. Rev. Cardiol"},{"key":"5766_CR3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","volume":"377","author":"F Farzadfar","year":"2011","unstructured":"Farzadfar, F., Finucane, M., Danaei, G. & Pelizzari, P. M. National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321country-years and 3\u00b70 million participants. Lancet 377, 578\u2013586 (2011).","journal-title":"Lancet"},{"key":"5766_CR4","first-page":"1","volume":"7","author":"AS Htet","year":"2017","unstructured":"Htet, A. S. et al. Lipid profiles and determinants of total cholesterol and hypercholesterolaemia among 25\u201374 year-old urban and rural citizens of the Yangon Region, Myanmar: A cross-sectional study. BMJ Open 7, 1\u20138 (2017).","journal-title":"BMJ Open"},{"key":"5766_CR5","doi-asserted-by":"crossref","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","volume":"9","author":"SR Joshi","year":"2014","unstructured":"Joshi, S. R. et al. Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study. PLoS ONE 9, e96808 (2014).","journal-title":"PLoS ONE"},{"key":"5766_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-016-0392-3","volume":"16","author":"FL Zhang","year":"2017","unstructured":"Zhang, F. L. et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: A population-based cross-sectional survey. Lipids Health Dis. 16, 1\u201313 (2017).","journal-title":"Lipids Health Dis."},{"key":"5766_CR7","doi-asserted-by":"crossref","unstructured":"Stamler, J. Established major coronary risk factors: Historical overview. Marmot M. Elliot P. Eds. Coronary Heart Disease Epidemiology: From Aetiology to Public Health 2, 18\u201331 (2005).","DOI":"10.1093\/acprof:oso\/9780198525738.003.0003"},{"key":"5766_CR8","unstructured":"WHO. World Health Organization Noncommunicable Diseases Country Profiles. WHO Library Cataloguing-in-Publication Data, Geneva, Switzerland 7 (2018)."},{"key":"5766_CR9","unstructured":"World Health Organization. Cardiovascular diseases (CVDs) fact sheet. World Health Organization (2017)."},{"key":"5766_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","volume":"1254","author":"L Badimon","year":"2012","unstructured":"Badimon, L. & Vilahur, G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: Inflammatory resolution versus thrombotic chaos. Ann. N. Y. Acad. Sci. 1254, 18\u201332 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"5766_CR11","first-page":"14348","volume":"7","author":"Q Najeeb","year":"2015","unstructured":"Najeeb, Q., Sameer, A. S., Aziz, R. & Hamid, S. Association of lipid profile and liver enzymes among non-alcoholic fatty liver disease patients attending a tertiary care hospital in northern indian. Int. J. Curr. Res. 7, 14348\u201314352 (2015).","journal-title":"Int. J. Curr. Res."},{"key":"5766_CR12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4254\/wjh.v7.i11.1450","volume":"7","author":"M Ahmed","year":"2015","unstructured":"Ahmed, M. Non-alcoholic fatty liver disease in 2015. World J. Hepatol. 7, 1450 (2015).","journal-title":"World J. Hepatol."},{"key":"5766_CR13","doi-asserted-by":"crossref","first-page":"e036663","DOI":"10.1136\/bmjopen-2019-036663","volume":"10","author":"X Ge","year":"2020","unstructured":"Ge, X., Zheng, L., Wang, M., Du, Y. & Jiang, J. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990\u20132017: A population-based observational study. BMJ Open 10, e036663 (2020).","journal-title":"BMJ Open"},{"key":"5766_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrgastro.2013.197","volume":"10","author":"K Ray","year":"2013","unstructured":"Ray, K. NAFLD-the next global epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 621 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"5766_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jgh3.12044","volume":"2","author":"S Alam","year":"2018","unstructured":"Alam, S. et al. Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh. JGH Open 2, 39\u201346 (2018).","journal-title":"JGH Open"},{"key":"5766_CR16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/44.10.8813074","volume":"44","author":"MH Hanigan","year":"1996","unstructured":"Hanigan, M. H. & Henry, E. Immunohistochemical detection of y-glutamyl transpeptidase in normal human tissue. J. Histochem. Cytochem. 44, 1101\u20131108 (1996).","journal-title":"J. Histochem. Cytochem."},{"key":"5766_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/20014091084227","volume":"38","author":"JB Whitfield","year":"2001","unstructured":"Whitfield, J. B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 38, 263\u2013355 (2001).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"5766_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: A guide for clinicians. CMAJ 172, 367\u2013379 (2005).","journal-title":"CMAJ"},{"key":"5766_CR19","doi-asserted-by":"crossref","first-page":"e00116","DOI":"10.1002\/edm2.116","volume":"3","author":"S Islam","year":"2020","unstructured":"Islam, S. et al. Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross-sectional study in Bangladeshi adults. Endocrinol. Diabetes Metab 3, e00116 (2020).","journal-title":"Endocrinol. Diabetes Metab"},{"key":"5766_CR20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1464-5491.2005.01581.x","volume":"22","author":"D-J Kim","year":"2005","unstructured":"Kim, D.-J. et al. Serum \u03b3-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet. Med. 22, 1134\u20131140 (2005).","journal-title":"Diabet. Med."},{"key":"5766_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2004.08.027","volume":"178","author":"D-H Lee","year":"2005","unstructured":"Lee, D.-H. & Jacobs, D. R. Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178, 327\u2013330 (2005).","journal-title":"Atherosclerosis"},{"key":"5766_CR22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"D Sanyal","year":"2015","unstructured":"Sanyal, D. et al. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J. Endocrinol. Metab 19, 597\u2013601 (2015).","journal-title":"Indian J. Endocrinol. Metab"},{"key":"5766_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2013","unstructured":"Nelson, R. H. Hyperlipidemia as a risk factor for cardiovascular disease. Primary Care: Clin. Office Pract. 40, 195\u2013211 (2013).","journal-title":"Primary Care: Clin. Office Pract."},{"key":"5766_CR24","doi-asserted-by":"crossref","unstructured":"Deb, S., Puthanveetil, P. & Sakharkar, P. A Population-Based Cross-Sectional Study of the Association. 2018 (2018).","DOI":"10.1155\/2018\/1286170"},{"key":"5766_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160180","volume":"11","author":"K Fatema","year":"2016","unstructured":"Fatema, K., Zwar, N. A., Milton, A. H., Ali, L. & Rahman, B. Prevalence of risk factors for cardiovascular diseases in Bangladesh: A systematic review and meta-analysis. PLoS ONE 11, 1\u201314 (2016).","journal-title":"PLoS ONE"},{"key":"5766_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3329\/uhj.v8i1.11662","volume":"8","author":"N Islam","year":"2012","unstructured":"Islam, N. et al. Prevalence of dyslipidemia and associated factors among the sub-urban Bangladeshi population. Univ. Heart J. 8, 15\u201319 (2012).","journal-title":"Univ. Heart J."},{"key":"5766_CR27","first-page":"444","volume":"13","author":"M Mostafa Zaman","year":"2006","unstructured":"Mostafa Zaman, M. et al. Plasma lipids in a rural population of Bangladesh. Eur. J. Cardiovasc. Prevent. Rehab. Off. J. Eur. Soc. Cardiol. Work. Groups Epidemiol. Prevent. Cardiac Rehab. Exercise Physiol. 13, 444\u2013448 (2006).","journal-title":"Eur. J. Cardiovasc. Prevent. Rehab. Off. J. Eur. Soc. Cardiol. Work. Groups Epidemiol. Prevent. Cardiac Rehab. Exercise Physiol."},{"key":"5766_CR28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12889-017-4617-9","volume":"18","author":"N Ali","year":"2017","unstructured":"Ali, N. et al. Hypertension prevalence and influence of basal metabolic rate on blood pressure among adult students in Bangladesh. BMC Public Health 18, 58 (2017).","journal-title":"BMC Public Health"},{"key":"5766_CR29","doi-asserted-by":"crossref","first-page":"e0206850","DOI":"10.1371\/journal.pone.0206850","volume":"13","author":"N Ali","year":"2018","unstructured":"Ali, N. et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS ONE 13, e0206850 (2018).","journal-title":"PLoS ONE"},{"key":"5766_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12872-019-1026-2","volume":"19","author":"N Ali","year":"2019","unstructured":"Ali, N. et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc. Disord. 19, 42 (2019).","journal-title":"BMC Cardiovasc. Disord."},{"key":"5766_CR31","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1038\/s41598-019-45680-4","volume":"9","author":"N Ali","year":"2019","unstructured":"Ali, N. et al. Relationship between serum uric acid and hypertension: A cross-sectional study in Bangladeshi adults. Sci. Rep. 9, 9061 (2019).","journal-title":"Sci. Rep."},{"key":"5766_CR32","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1038\/s41598-020-64884-7","volume":"10","author":"N Ali","year":"2020","unstructured":"Ali, N. et al. Association between serum uric acid and metabolic syndrome: A cross-sectional study in Bangladeshi adults. Sci. Rep. 10, 7841 (2020).","journal-title":"Sci. Rep."},{"key":"5766_CR33","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1038\/s41598-021-86216-z","volume":"11","author":"N Ali","year":"2021","unstructured":"Ali, N. et al. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Sci. Rep. 11, 6640 (2021).","journal-title":"Sci. Rep."},{"key":"5766_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13098-019-0446-6","volume":"11","author":"T Haque","year":"2019","unstructured":"Haque, T., Rahman, S., Islam, S., Molla, N. H. & Ali, N. Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals. Diabetol. Metab Syndr. 11, 49 (2019).","journal-title":"Diabetol. Metab Syndr."},{"key":"5766_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12872-020-01411-6","volume":"20","author":"S Rahman","year":"2020","unstructured":"Rahman, S., Islam, S., Haque, T., Kathak, R. R. & Ali, N. Association between serum liver enzymes and hypertension: A cross-sectional study in Bangladeshi adults. BMC Cardiovasc. Disord. 20, 128 (2020).","journal-title":"BMC Cardiovasc. Disord."},{"key":"5766_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99623-z","author":"NH Molla","year":"2021","unstructured":"Molla, N. H. et al. Assessment of the relationship between serum uric acid levels and liver enzymes activity in Bangladeshi adults. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-99623-z (2021).","journal-title":"Sci. Rep."},{"key":"5766_CR37","doi-asserted-by":"crossref","first-page":"21339","DOI":"10.1038\/s41598-021-00839-w","volume":"11","author":"AD Mou","year":"2021","unstructured":"Mou, A. D. et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci. Rep. 11, 21339 (2021).","journal-title":"Sci. Rep."},{"key":"5766_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86216-z","author":"N Ali","year":"2021","unstructured":"Ali, N., Sumon, A. H. & Fariha, K. A. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Sci. Rep https:\/\/doi.org\/10.1038\/s41598-021-86216-z (2021).","journal-title":"Sci. Rep"},{"key":"5766_CR39","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, E. and T. of H. B. C. in A. Executive Summary of the Third Report (NCEP)-Adult Treatment Panel III. J. Am. Med. Associ. 285, 2486\u20132497 (2001).","DOI":"10.1001\/jama.285.19.2486"},{"key":"5766_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-8981(02)00341-8","volume":"327","author":"G Schumann","year":"2003","unstructured":"Schumann, G. & Klauke, R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: Preliminary upper reference limits obtained inhospitalized subjects. Clin. Chim. Acta 327, 69\u201379 (2003).","journal-title":"Clin. Chim. Acta"},{"key":"5766_CR41","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/clinchem\/32.8.1593a","volume":"32","author":"NW Tietz","year":"1986","unstructured":"Tietz, N. W. & Shuey, D. F. Reference intervals for alkaline phosphatase activity determined by the IFCC and AACC reference methods. Clin. Chem. 32, 1593\u20131594 (1986).","journal-title":"Clin. Chem."},{"key":"5766_CR42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/1753-0407.12524","volume":"9","author":"PH Marathe","year":"2017","unstructured":"Marathe, P. H., Gao, H. X. & Close, K. L. American diabetes association standards of medical care in diabetes 2017. J. Diabetes 9, 320\u2013324 (2017).","journal-title":"J. Diabetes"},{"key":"5766_CR43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3329\/uhj.v5i1.3436","volume":"5","author":"SA Ahsan","year":"2009","unstructured":"Ahsan, S. A. et al. Detection of ischaemic heart disease with risk factors in different categories of employees of University Grants Commission. Univ. Heart J. 5, 20\u201323 (2009).","journal-title":"Univ. Heart J."},{"key":"5766_CR44","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/ijerph15091944","volume":"15","author":"B Bhowmik","year":"2018","unstructured":"Bhowmik, B. et al. Serum lipid profile and its association with diabetes and prediabetes in a rural bangladeshi population. Int. J. Environ. Res. Public Health 15, 1944 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"5766_CR45","first-page":"327","volume":"10","author":"KN Choudhury","year":"2014","unstructured":"Choudhury, K. N., Mainuddin, A. K. M., Wahiduzzaman, M. & Islam, S. M. S. Serum lipid profile and its association with hypertension in Bangladesh. Vasc. Health Risk Manag. 10, 327\u2013332 (2014).","journal-title":"Vasc. Health Risk Manag."},{"key":"5766_CR46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/IJGM.S160555","volume":"11","author":"M Alshamiri","year":"2018","unstructured":"Alshamiri, M. et al. Expert opinion on the applicability of dyslipidemia guidelines in Asia and the middle east. Int. J. Gener. Med. 11, 313\u2013322 (2018).","journal-title":"Int. J. Gener. Med."},{"key":"5766_CR47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ihj.2013.06.004","volume":"65","author":"AKM Monwarul Islam","year":"2013","unstructured":"Monwarul Islam, A. K. M. & Majumder, A. A. S. Coronary artery disease in Bangladesh: A review. Indian Heart J. 65, 424\u2013435 (2013).","journal-title":"Indian Heart J."},{"key":"5766_CR48","first-page":"8","volume":"02","author":"S Kumar Das","year":"2012","unstructured":"Kumar Das, S. Serum lipid profile among urban and rural Bangladeshi population. J. Obes. Weight Loss Ther. 02, 8\u201311 (2012).","journal-title":"J. Obes. Weight Loss Ther."},{"key":"5766_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.15580\/GJMS.2013.5.011313373","volume":"3","author":"AS Atiba","year":"2013","unstructured":"Atiba, A. S., Oparinde, D. P., Adeyemi, O., Jimoh, A. K. & Adepeju, A. A. Liver enzymes and lipid profile among type 2 diabetic patients in Osogbo, By. Greener J. Med. Sci. 3, 174\u2013178 (2013).","journal-title":"Greener J. Med. Sci."},{"key":"5766_CR50","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/ijerph15081658","volume":"15","author":"H Kim","year":"2018","unstructured":"Kim, H. & Han, M. Association between serum liver enzymes and metabolic syndrome in Korean adults. Int. J. Environ. Res. Public Health 15, 1658 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"5766_CR51","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2337\/diabetes.53.10.2623","volume":"53","author":"AJG Hanley","year":"2004","unstructured":"Hanley, A. J. G. et al. Elevations in markers of liver injury and risk of type 2 diabetes. Diabetes 53, 2623\u20132632 (2004).","journal-title":"Diabetes"},{"key":"5766_CR52","first-page":"257","volume":"81","author":"LJ de Souza","year":"2003","unstructured":"de Souza, L. J. et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian State of Rio de Janeiro. Arq. Bras. Cardiol. 81, 257\u2013264 (2003).","journal-title":"Arq. Bras. Cardiol."},{"key":"5766_CR53","doi-asserted-by":"crossref","unstructured":"Lieber, C. S. Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. in Alcohol vol. 34 9\u201319 (Elsevier, 2004).","DOI":"10.1016\/j.alcohol.2004.07.008"},{"key":"5766_CR54","first-page":"160","volume":"15","author":"J Arauz","year":"2016","unstructured":"Arauz, J., Ramos-Tovar, E. & Muriel, P. Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside. Ann. Hepatol. 15, 160\u2013173 (2016).","journal-title":"Ann. Hepatol."},{"key":"5766_CR55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715760410001694026","volume":"38","author":"D-H Lee","year":"2004","unstructured":"Lee, D.-H., Blomhoff, R. & Jacobs, D. R. Review is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radical Res. 38, 535\u2013539 (2004).","journal-title":"Free Radical Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05766-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T15:51:09Z","timestamp":1674661869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05766-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05766-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"31 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1711"}}